Ranjit Bindra
Professor of Therapeutic Radiology, Pathology, and Neurosurgery, Yale School of Medicine
Elected to the Academy in 2026
Education
Yale University, BS, Molecular Biophysics & Biochemistry; Yale School of Medicine, MD, Medicine; Yale School of Medicine, PhD, Experimental Pathology
Professional Areas
Translational cancer research, DNA damage response, synthetic lethality, brain tumor therapeutics, and oncology drug development. Integrates molecular biology and biomedical engineering to design and advance novel targeted agents, including novel DNA-damaging agents and nanoparticle-delivered drugs.
Citation
For uncovering novel cancer-associated DNA repair vulnerabilities, and for directly translating them into clinical trials, including new classes of brain tumor therapeutics.